These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

907 related items for PubMed ID: 24690149

  • 1. Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets.
    Maltais AK, Stittelaar KJ, Veldhuis Kroeze EJ, van Amerongen G, Dijkshoorn ML, Krestin GP, Hinkula J, Arwidsson H, Lindberg A, Osterhaus AD.
    Vaccine; 2014 May 30; 32(26):3307-15. PubMed ID: 24690149
    [Abstract] [Full Text] [Related]

  • 2. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.
    Vaccine; 2012 Jul 06; 30(32):4884-91. PubMed ID: 22537989
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.
    Pearce MB, Belser JA, Houser KV, Katz JM, Tumpey TM.
    Vaccine; 2011 Apr 05; 29(16):2887-94. PubMed ID: 21338676
    [Abstract] [Full Text] [Related]

  • 4. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.
    Baras B, de Waal L, Stittelaar KJ, Jacob V, Giannini S, Kroeze EJ, van den Brand JM, van Amerongen G, Simon JH, Hanon E, Mossman SP, Osterhaus AD.
    Vaccine; 2011 Mar 03; 29(11):2120-6. PubMed ID: 21238573
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets.
    Stittelaar KJ, Veldhuis Kroeze EJ, Rudenko L, Dhere R, Thirapakpoomanunt S, Kieny MP, Osterhaus AD.
    Vaccine; 2011 Nov 15; 29(49):9265-70. PubMed ID: 21945964
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.
    Han HJ, Song MS, Park SJ, Byun HY, Robles NJC, Ha SH, Choi YK.
    J Microbiol; 2019 Feb 15; 57(2):163-169. PubMed ID: 30706345
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P.
    Vaccine; 2017 Jul 24; 35(33):4177-4183. PubMed ID: 28668565
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V, Chichester JA, Ebensen T, Schwarz K, Hartman CE, Shoji Y, Guzmán CA, Yusibov V, Sewald K, Braun A.
    Vaccine; 2014 May 30; 32(26):3216-22. PubMed ID: 24731807
    [Abstract] [Full Text] [Related]

  • 12. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
    Ann J, Samant M, Rheaume C, Dumas C, Beaulieu E, Morasse A, Mallett C, Hamelin ME, Papadopoulou B, Boivin G.
    Vaccine; 2014 Sep 29; 32(43):5730-9. PubMed ID: 25173481
    [Abstract] [Full Text] [Related]

  • 13. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S, Ainai A, Suzuki T, Kurata T, Hasegawa H.
    Jpn J Infect Dis; 2016 Sep 29; 69(3):165-79. PubMed ID: 27212584
    [Abstract] [Full Text] [Related]

  • 14. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M, Wang Z, Sreenivasan CC, Hause BM, Gourapura J Renukaradhya, Li F, Francis DH, Kaushik RS, Khatri M.
    Vaccine; 2015 Jan 15; 33(4):542-8. PubMed ID: 25437101
    [Abstract] [Full Text] [Related]

  • 15. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z, Chen Q, Fang F, Zheng M, Chen Z.
    Vaccine; 2010 Nov 10; 28(48):7690-8. PubMed ID: 20870054
    [Abstract] [Full Text] [Related]

  • 16. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
    Wang SH, Smith D, Cao Z, Chen J, Acosta H, Chichester JA, Yusibov V, Streatfield SJ, Fattom A, Baker JR.
    Vaccine; 2019 Mar 14; 37(12):1591-1600. PubMed ID: 30795941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768855
    [Abstract] [Full Text] [Related]

  • 20. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.